/ Pfizer
/ Best Stocks
3 Value Stocks Worth Buying in Current Market Conditions
Big Pharma, Big Tech and REIT is on the value menu. Discount opportunities at this level are rare.
April 01, 2025
Pfizer Targets Up to $64B Revenue in 2025 Amid Strategic Cost Savings
Pfizer projects 2025 revenues between $61 billion and $64 billion, with a focus on cost savings and strategic initiatives to drive growth.
December 17, 2024
Starboard Value Reportedly Acquires $1B Stake in Pfizer as Stock Lags S&P 500 by 46%
Activist investor Starboard Value has reportedly taken a $1 billion stake in pharmaceutical giant Pfizer.
October 07, 2024
Top 3 Discounted Value Stocks Worth Buying Now
These stocks have a large cushion while retaining intrinsic value.
September 30, 2024
The Weight Loss Market Can Surge to $400 B by 2032, and these Stocks Will Rule it
Despite Novo Nordisk's momentum, Eli Lilly seems a better long-term bet. Pfizer could surprise everyone from an undervalued position.
July 12, 2024More from The Tokenist / Pfizer
3 Defensive Stocks to Protect Your Portfolio in 2024
April 23, 2024
Three Safe Dividend Paying Stocks With High Yields to Hold in 2024
December 20, 2023
Pfizer Sinks Premarket After Posting Weak Guidance for 2024
December 13, 2023
Pfizer’s Stock is Down 44% YTD as Woes Continue
December 01, 2023
3 Stocks That Could Benefit From Pfizer’s COVID-19 Vaccine
November 16, 2020
Back to 
